Editorial: The AIDS crisis, cost-effectiveness and academic activism.
- When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study.
- Authors: Badri M, Cleary S, Maartens G, Pitt J, Bekker LG, Orrell C, Wood R
- Issue date: 2006
- HIV/AIDS control in sub-Saharan Africa.
- Authors: Hanson S
- Issue date: 2001 Oct 19
- The cost-effectiveness of highly active antiretroviral therapy, Canada 1991-2001.
- Authors: Beck EJ, Mandalia S, Gaudreault M, Brewer C, Zowall H, Gilmore N, Klein MB, Lalonde R, Piché A, Hankins CA
- Issue date: 2004 Dec 3
- Costs decline with HAART.
- Issue date: 2000 Dec